Bacterial topoisomerase II (DNAgyrase) is an essential enzyme that is known to be target of two major classes of antibiotics. The quinolones, synthetic products typified by nalidixic and oxolinic acids, inhibit the A subunit, probably by interfering with the DNA-rejoining step of the gyrase-mediated, DNAstrand-passing reaction1~4). The coumarins, natural products that inhibit gyrase, probably by competing with ATP for binding to the B subunit of the enzyme5'6), include novobiocin, coumermycin Al, and derivatives. Here we describe an assay system which detects both classes ofgyrase inhibitors in addition to the antibiotic cinodine, a novel inhibitor of bacterial DNA gyrase7).
Materials and Methods
Bacterial Strains Bacillus subtilis strain DIN23contains a chromosomal fusion of a DNA damage-inducible {din)
promoter to the Escherichia coli lacZ gene8), and was obtained from R. Yasbin. The strain was derived from strain YB886 (metB5trpC2xin-lSPP-). We constructed a recM13 derivative of strain DIN23,
i.e., DIN23recA/73, as previously described9).
Fusion strains were resistant to erythromycin (1 /ig/ml) and lincomycin (25^g/ml) as a result of the TnP77 insertion. 
Results and Discussion
The DIN Assay A number of DNAdamaging agents and DNA gyrase inhibitors are known to induce an SOS-like response in B. subtilis8'9'12). The relevant studies have madeuse of B. subtilis strains whichencode a din promoter fused to the lacZ gene of E. coli, and which, therefore, produce /?-galactosidase when the SOS response is induced. Recent studies of the B. subtilis recM13 mutation have indicated that recM13 mutants were poorly induced for the SOS response by both UV light and mitomycin C, whereas induction with the DNAgyrase subunit A inhibitor nalidixic acid appeared normal9'1 3). Based (Table 1) . This finding led to the use of the DIN assay to detect potential inhibitors of DNAgyrase, in that any compound that induces both of these strains is suspected to inhibit DNAgyrase.
That the recM13 strain was induced by compoundswhich do not normally induce an SOS response was an interesting and unexpected result.
The altered SOS regulation conferred by the recM13 mutation is discussed elsewhere9). The mutation appears to confer a low-level constitutive SOS response, and, since the mutation also confers increased sensitivity to DNAdamaging agents such as mitomycin C, such drugs maykill the mutant strain before it can mount an SOSresponse. antibiotics. ' DNAgyrase inhibitor, subunit not determined. j /?-Galactosidase induction, scored as a " + " or a " -" was determined by means of the plate induction assay. Drugs were applied to assay plates in 1~20/A volumes. k Lowest amount of drug which induced /?-galactosidase.
